Patents by Inventor Sung James Lee

Sung James Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230278950
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 7, 2022
    Publication date: September 7, 2023
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 11524935
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: December 13, 2022
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20210070694
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 23, 2020
    Publication date: March 11, 2021
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20190194125
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 27, 2019
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 10202335
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: February 12, 2019
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 9907777
    Abstract: The invention is directed to a method of treating bipolar disorder in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharmaceutically acceptable salt or amide thereof.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: March 6, 2018
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20170355668
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 25, 2017
    Publication date: December 14, 2017
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20170349541
    Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2017
    Publication date: December 7, 2017
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 9688620
    Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: June 27, 2017
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20170151209
    Abstract: The invention is directed to a method of treating bipolar disorder in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharmaceutically acceptable salt or amide thereof.
    Type: Application
    Filed: February 14, 2017
    Publication date: June 1, 2017
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 9663455
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: May 30, 2017
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 9610274
    Abstract: The invention is directed to a method of treating bipolar disorder in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharmaceutically acceptable salt or amide thereof.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 4, 2017
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20150025137
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 22, 2015
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20150011625
    Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 8927602
    Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: January 6, 2015
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 8895609
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: November 25, 2014
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20120252892
    Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 1, 2010
    Publication date: October 4, 2012
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20120245226
    Abstract: The invention is directed to a method of treating attention-deficit/hyperactivity disorder (ADHD) in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 3, 2010
    Publication date: September 27, 2012
    Inventors: Sung James Lee, Susan Marie Melnick
  • Patent number: 8232315
    Abstract: The invention is directed to a method of treating addiction to drugs of abuse in a subject, comprising administering a therapeutically effective amount of a cabamoyl compound, or pharmaceutically acceptable salt or ester thereof.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: July 31, 2012
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sung James Lee, Susan Marie Melnick
  • Publication number: 20120004300
    Abstract: The invention is directed to a method of treating bipolar disorder in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharmaceutically acceptable salt or amide thereof.
    Type: Application
    Filed: June 30, 2010
    Publication date: January 5, 2012
    Applicant: SK HOLDINGS CO., LTD.
    Inventors: Sung James Lee, Susan Marie Melnick